ArticlePharmacology research & perspectives2024

A dose-adjusted, open-label, pilot study of the safety, tolerability, and pharmacokinetics of STC3141 in critically ill patients with sepsis.

Rinaldo Bellomo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.